Displaying items by tag: women

Do you have a loved one with agitation associated with Alzheimer’s dementia? Is their agitation becoming overwhelming? Examples of some easily identifiable agitated behaviors are: restlessness, screaming, shouting, throwing things, resistiveness, constant unwarranted requests for attention or help, pacing/aimless wandering, kicking, hitting others or self, pushing people, hurting self or others, tearing things or destroying property. In this study, researchers want to find out if an investigational drug called AVP-786 is safe and effective (useful) in managing agitation in adults with Alzheimer’s dementia, when compared to a placebo. If you are a caregiver for a person with Alzheimer’s disease, please call (205) 996-5987 or email lalexander@uabmc.edu for more information.

We are enrolling opioid users without a history of psychosis, endocrine diseases, inflammatory diseases, or autoimmune diseases. If you meet these criteria you may be eligible to participate in a research study. Compensation provided up to $20. For more information, please call the UAB Office of Psychiatric Research at 205-934-8336.
You may be eligible to participate in a research study about the effects of Exercise and Metoprolol (a blood pressure pill) on a protein in your blood. This protein is related to heart disease. Eligible participants must be Healthy men and women, African American or Caucasians and have no history of diabetes, heart problems, or kidney problems. The study involves performing exercise, taking metoprolol, consuming prepared meals, and collecting blood samples. Participants will be compensated. Please e-mail Nehal Vekariya at nvekariya@uabmc.edu if you are interested.
You may be eligible to participate in a research study about the effects of sacubitril/valsartan on how your body handles insulin and glucose. This medication is related to the heart. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart problems, or kidney problems. The study involves performing some exercise, taking sacubitril/valsartan, and collecting blood samples. Participants will be compensated. Please e-mail Nehal Vekariya at nvekariya@uabmc.edu if you are interested.
The Neuroinflammation, Pain and Fatigue Lab at UAB is looking for women with Fibromyalgia, and women who are healthy and without pain. Participants will come to UAB for a 2-hour screening visit and a 9-hour (all-day) study session. During the study session, we will induce a temporary immune response and assess its effect on fibromyalgia symptoms, including pain and markers of immune activity. You will provide blood samples and undergo brain imaging before and after the immune activation procedure. You will be paid $650 for completing both visits. Participants must be: currently suffering from moderate to severe Fibromyalgia, or be a healthy female and ages 18-55, not pregnant or planning to become pregnant, without significant other medical conditions such as heart disease, not using any opioid medication, for example, Norco, Tramadol, Percocet. To participate, please contact Indonesia at 205-289-8748 or e-mail ijordan@uab.edu.
UAB's Urogynecology and Pelvic Reconstructive Surgery is conducting a 3 month at-home non-invasive lower leg stimulation study. You may be eligible if you are female and 18 years of age and older, have a history of chronic Bowel Leakage for at least 6 months, and have tried at least 2 treatments, including medications, diet, and pelvic exercises. Compensation will be provided. If you would like more information about the study, please contact 205-934-5498.
Are you taking Metformin alone or metformin with a sodium-glucose transport protein 2 (SGLT2) inhibitor to treat your diabetes? The University of Alabama at Birmingham, Department of Nutrition Sciences, is conducting a 39-week research study to see how two new study medicines work together on blood sugar levels in people with Type 2 diabetes. Qualified participants will receive study-drug free of charge and may be compensated for time and travel. For more information, and to check your eligibility to join, please contact (205) 996-4015 or email at ccnrn@uab.edu.
You could be eligible to participate if you are 18 or older and a premenopausal female. Also, If you have been diagnosed with endometriosis, and are experiencing pain associated with endometriosis. There is no cost for your participation. For more information, contact our research team at 205-934-1322. Compensation is available for those who qualify.
The purpose of the study is to measure maximum walking speed and step length with virtual reality and customizable exercise games as feedback sources on a robotic treadmill. The targeted population is individuals with hemiparesis, in a chronic and stable stroke stage, who are able to follow instructions, and able to walk independently for at least three minutes. Based on a phone screening, eligible participants will attend up to two separate sessions at UAB Spain Rehabilitation Center. In each session, they will go into different walking or stepping performance conditions. The session will last about two hours, and participants will be paid 30$ per session for their time and effort. For more information please call Saleh Alhirsan at (205) 261-3853 or by email atalhirsan@uab.edu.
We are looking for adults between 21-55 years old and diagnosed with Attention Deficit and Hyperactivity Disorder (ADHD), and use stimulant medication to participate in our study. We want to determine the role of ADHD stimulant medication on balance and other factors, such as physical activity in improving balance performance. We hypothesize that ADHD will improve balance performance in adults with ADHD. We also hypothesize that moderate to vigorous physical activity behaviors will positively influence balance performance in this population. Participants will be required to make two visits. Once on-medication; and on the second visit, we will ask participants to forgo ADHD medication 24 hours before the testing. For more information please contact Mansour at (205) 503-2977, or by email at amansour@uab.edu.
The purpose of the SCIPE study is to examine two 8-week remotely delivered exercise interventions: Movement-to-Music, and Standard Exercise Training. Enrolled participants will be randomized into one of three groups: M2M, SET, or attention control. The primary goal of this study is to examine changes in physical activity levels after the 8-week M2M and SET interventions. We hypothesize that M2M and SET participants will have significant increases in physical activity, sleep quality, quality of life, and decreases in pain compared to the Attention Control group after the 8-week intervention. The secondary aim is to examine the effects of the M2M and SET interventions on health and quality of life outcomes. Exercise enjoyment in M2M and SET participants will also be explored. The tertiary aim is to evaluate the demographic, clinical, and psychosocial variables of two participant groups: 1) compliant participants who completed ≥ 50% of the intervention, and 2) non-compliant participants who completed post-testing but only 50% of the intervention, or did not complete post-testing. The SCIPE study will take place entirely online. The exercise program will be delivered to you in a video format, so you can exercise anywhere that is convenient for you. For more information please contact (205) 209-2245 or email scipe@uab.edu.
You may be eligible to participate in this important study if you are premenopausal female age 18-49, if you have been diagnosed with endometriosis, and are experiencing moderate to severe pain associated with your endometriosis. There is no cost for your participation. For more information, contact our research team at 205-934-1322. Compensation is available for those who qualify. https://endometriosis-study.com/
If you are 18 years of age or older and currently taking the blood thinners Xarelto (rivaroxaban) or Eliquis (apixaban), you may be eligible to participate in a research study. This study is being done to determine how your kidney function affects how you metabolize Xarelto or Eliquis. The study involves keeping a medication log for one week and one (12 hour) visit to UAB where we will collect blood samples at different times during the day. Participants will be compensated $150 for completing the one-day study visit. If you are interested or for more information, please contact our research team at pkpdstudy@uabmc.eduor 205-917-9800.
You may be eligible to participate in a research study about the effects of Sacubitril/Valsartan on how your body handles insulin and glucose. This medication is related to the heart. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart problems, or kidney problems. The study involves exercising, taking sacubitril/valsartan or valsartan, and collecting blood samples. Participants will be compensated. Please e-mail Dr. Vibhu Parcha, vparcha@uabmc.edu if you are interested. 
You may be eligible to participate in a research study about the effects of exercise and Metoprolol, a blood pressure pill, on a protein in your blood. This protein is related to heart disease. Eligible participants must be healthy men and women, African American or Caucasian with no history of diabetes, heart problems, or kidney problems. The study involves exercising, taking metoprolol, consuming prepared meals, and collecting blood samples. Participants will be compensated. Please email Dr. Vibhu Parcha at vparcha@uabmc.edu if you are interested.
If you are 18 years of age or older, have tried at least 1 antidepressant medication, are feeling sad, down, hopeless, guilty, tense, or irritable, and are in good physical health, you may be eligible to participate in a research study comparing medications with transcranial magnetic stimulation. You will receive compensation for your time. Please leave a voice message at (205) 934-2484 or email lalexander@uabmc.edu for more information.

The RECOVER study will investigate the use of Vagus Nerve Stimulation (VNS) Therapy in up to 1,000 people across the United States. To join the RECOVER study you must be 18 years or older and: currently depressed, have depression (or bipolar depression) that has lasted for at least two years or recurred several times, and have tried at least four types of antidepressant treatments and not found them helpful. Please leave a voice message at (205) 975-0068 or email candacegreen@uabmc.edu for more information.

If you are at least 18 years of age, can read and write in English, are generally healthy, and have no history of mental illness or psychiatric disorders, please leave a voice message at (205) 934-2484 or email lalexander@uabmc.edu for more information.
You may be able to participate in this study if you: are 18 years of age or older, have been diagnosed with major depressive disorder, MDD, and have not adequately responded to at least 2 different antidepressant treatments. Please leave a voice message at (205) 934-2484 or email lalexander@uabmc.edu for more information.
If you have Major Depressive Disorder (MDD) that hasn’t responded to anti-depressant medication, learn about this research study of an investigational drug for MDD. As part of their study participation, patients will be regularly evaluated and closely monitored by a team of medical professionals. To pre-qualify for this study, you must: be 18 to 65 years of age; have been diagnosed with MDD; be in a current depressive episode for at least 8 weeks but not more than 12 months; and have been taking an antidepressant medication for at least the last 8 weeks. Additional criteria will apply. All study-related visits, tests, and study drugs will be provided at no cost. In addition, reimbursement for study-related travel may be provided. Please leave a voice message at (205) 934-2484 or email lalexander@uabmc.edu for more information.
If you have major depressive disorder (MDD) and are in a current depressive episode, we invite you to learn about a research study of an investigational drug that is taken with your current antidepressant medication. In this study, researchers will evaluate the safety and efficacy of the investigational drug as an add-on therapy to your current antidepressant medication. To prequalify for this study you must be 18 to 65 years of age, have been diagnosed with recurrent MDD, be in a current major depressive episode for at least the last 8 weeks, and not experiencing a satisfactory improvement in your symptoms of depression with your current treatment. All study-related visits, tests, and drugs will be provided at no cost. In addition, reimbursement for study-related travel may be provided. Please leave a voice message at (205) 934-2484 or email lalexander@uabmc.edu for more information.
This is a paid research opportunity for adults who provide care for adult loved ones 45 years or older. We are actively recruiting for a research study to examine caregivers’ experiences and health outcomes. To be eligible, caregiver participants need to commit to providing care for their loved ones at least five hours weekly, and their loved ones need to be ages 45 and older. The study takes approximately 45 minutes to complete and can be completed via our online survey or over the phone with one of our trained research assistants. Participants will receive a $20 gift card for completing the study. The link to complete the study is: https://uab.co1.qualtrics.com/jfe/form/SV_bmAfy0dohaFEciG. For more information, please call and leave a voicemail for our research lab at (205) 975-9452, or email Wesley Browning at wbro9119@uab.edu, or Celine Atkins at gcat347@uab.edu.
The University of Alabama at Birmingham, Department of Nutrition Sciences, is conducting a research study to evaluate the effectiveness of an investigational drug to treat people with Type 2 Diabetes and obesity. To qualify, you must have Type 2 Diabetes, older than 18 years old, moderately overweight, diet-controlled or taking oral diabetes medications. Qualified participants will receive the study drug free of charge and compensation for time and travel. For more information, and to see if you might be eligible to join, please contact (205) 996-4015 or email at ccnrn@uab.edu.
Looking for individuals between the ages of 18-70 with a diagnosis of traumatic brain injury, spinal cord injury, spina bifida, cerebral palsy, stroke, Parkinson disease, or multiple sclerosis to participate in Movement-to-Music (M2M), a rhythmic-based exercise program provided entirely remotely from Lakeshore Foundation. You may be eligible if you have stable cardiovascular conditions and have not participated in a similar research study in the past 6 months. All equipment for completing the program and additional compensation provided. To learn more about this opportunity and if you are eligible, please call Lori Theriot at (205) 313-7455 or email m2mstudy@uab.edu.
We are looking for adults with type 2 diabetes for a research study to see if eating large amounts of whole fruit can improve your blood sugar and reduce your need for diabetes medications. You may be eligible if you are 20-65 years old, overweight (BMI 27-45), diagnosed with type 2 diabetes within the last 6 years, and are not taking insulin. Participants will be provided with meals for 12 weeks, a high-speed Vita-Mix blender, and $1,375 for completing the study. Since this study is time-intensive, we are seeking only highly motivated and dedicated participants. If you are interested, please complete the brief electronic form at http://bit.ly/fruit_study. For more information, please contact Cody Hanick at chanick@uab.edu or (262) 923-0672.
Page 2 of 9